Free Trial

AXA (OTCMKTS:AXAHY) Reaches New 12-Month High - Here's What Happened

AXA logo with Finance background

AXA SA (OTCMKTS:AXAHY - Get Free Report) reached a new 52-week high during trading on Tuesday . The company traded as high as $44.40 and last traded at $43.92, with a volume of 111877 shares trading hands. The stock had previously closed at $43.12.

Analyst Ratings Changes

AXAHY has been the topic of a number of analyst reports. Morgan Stanley reaffirmed an "overweight" rating on shares of AXA in a report on Wednesday, March 5th. The Goldman Sachs Group raised shares of AXA from a "hold" rating to a "strong-buy" rating in a research report on Wednesday, April 2nd.

Get Our Latest Research Report on AXA

AXA Price Performance

The company has a 50-day simple moving average of $41.56 and a two-hundred day simple moving average of $38.30.

About AXA

(Get Free Report)

AXA SA, through its subsidiaries, provides insurance, asset management, and banking services worldwide. The company operates through six segments: France; Europe; AXA XL; Asia, Africa & EME-LATAM; AXA Investment Managers; and Transversal & Other segments It offers life and savings insurance products, such as savings and retirement, other health, and personal protection products.

Read More

Should You Invest $1,000 in AXA Right Now?

Before you consider AXA, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and AXA wasn't on the list.

While AXA currently has a Strong Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

20 Stocks to Sell Now Cover

Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.

Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Palantir’s Big Moves: Profit-Taking, Price Targets & AI Potential
Buy Early: 3 Tech Trends With Millionaire-Making Potential
SMCI Stumbles on Earnings: Why Some Investors Still Want In

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines